{
    "Clinical Stage IV": {
        "First-line Systemic Therapy": {
            "Driver Mutation Positive": "Targeted Therapy (See NSCL-17)",
            "Driver Mutation Negative": "Immunotherapy +/- Chemotherapy (See NSCL-18)"
        }
    },
    "footnotes": {
        "1": "See Principles of Molecular and Biomarker Analysis (NSCL-G)."
    }
}